Altria Group, Inc. (MO)
Altria Group: Buy, Sell, or Hold?
Altria stock has lagged the market in recent years. Yet shares are undeniably cheap, sporting an 8.6% dividend yield.
Can NJOY Help Propel Altria Group Stock Higher?
The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth.
Want $1,000 in Super-Safe Dividend Income? Buy $11,862 of This Ultra-High-Dividend Yield Stock
Altria Group's cigarette volumes are declining, but price increases are helping to maintain profits. The company has plenty of room to maintain or grow its dividend payments.
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria seeks FDA marketing order for oral nicotine pouch products
Tobacco giant Altria said on Wednesday it had submitted Premarket Tobacco Product Applications (PMTAs) to the U.S. Food and Drug Administration for its on! Plus oral nicotine pouch products.
Altria: 8.5% Dividend Looks More Attractive In An Overheated Stock Market
Altria Group is facing several challenges which are reflected in its rock-bottom valuation, but it has some core strengths which make the stock a Buy. The biggest issue is the secular decline in shipment volume of its smokeable products, which declined by a staggering 10 percentage points YoY in the recent quarter. However, the company is making up for these lost volumes with price increases, and the worst-case scenario for volume decline is also not too bad for the long-term EPS trajectory.
Altria (MO) Stock Dips While Market Gains: Key Facts
Altria (MO) concluded the recent trading session at $46.42, signifying a -0.06% move from its prior day's close.
Altria Group Is Not A Buy. Here's Why
Cigarette volumes keep declining, which is especially concerning given MO's recent inability to offset the negative volume effect with pricing power. The Company tries navigating the market with alternative product categories, and there's some positive news regarding that. However, the alternative product segments also face some headwinds (NJOY), or MO is yet to launch its first products (heated tobacco sticks).
Altria (MO) Increases Despite Market Slip: Here's What You Need to Know
Altria (MO) closed the most recent trading day at $46.45, moving +1.55% from the previous trading session.
Altria's (MO) Smoke-Free Growth Underway With Latest FDA Nod
Altria's (MO) NJOY obtains authorization from the U.S. Food and Drug Administration for menthol e-vapor products.
3 Undervalued Dividend Stocks to Buy in June
24/7 Insights Dividend stocks can supply investors with a steady stream of passive income.
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers
WASHINGTON — The Food and Drug Administration on Friday authorized the first menthol-flavored electronic cigarettes for adult smokers, acknowledging that vaping flavors can reduce the harms of traditional tobacco smoking.
